Vicapsys Life Sciences, Inc. Cash And Cash Equivalents At Carrying Value

Quick Answer

Vicapsys Life Sciences, Inc. reported Cash And Cash Equivalents At Carrying Value of $9.4 thousand for the year ending 2023.

  • Vicapsys Life Sciences, Inc. showed a decrease of -33.2% in Cash And Cash Equivalents At Carrying Value from 2022 to 2023.
  • This data is from Vicapsys Life Sciences, Inc.'s annual report (Form 10-K), filed with the SEC on October 21, 2024.
  • XBRL data for this metric is available from 2019 to 2023 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
  • Over the full 5 years of available data (2019 to 2023), Vicapsys Life Sciences, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 96.4%.
  • Historical annual values: Fiscal year 2023: $9.4 thousand | Fiscal year 2022: $14.1 thousand | Fiscal year 2021: $217.3 thousand | Fiscal year 2020: $1.3 thousand | Fiscal year 2019: $264.2 thousand.
  • Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: